Back to Search
Start Over
Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series.
- Source :
-
Leukemia & lymphoma [Leuk Lymphoma] 2019 Dec; Vol. 60 (13), pp. 3292-3295. Date of Electronic Publication: 2019 Jun 27. - Publication Year :
- 2019
- Subjects :
- Aged
Dasatinib adverse effects
Female
Fusion Proteins, bcr-abl genetics
Humans
Imatinib Mesylate adverse effects
Intervertebral Disc Degeneration diagnosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Male
Myelitis, Transverse diagnosis
Optic Neuritis diagnosis
Fusion Proteins, bcr-abl antagonists & inhibitors
Intervertebral Disc Degeneration chemically induced
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Myelitis, Transverse chemically induced
Optic Neuritis chemically induced
Protein Kinase Inhibitors adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1029-2403
- Volume :
- 60
- Issue :
- 13
- Database :
- MEDLINE
- Journal :
- Leukemia & lymphoma
- Publication Type :
- Report
- Accession number :
- 31246142
- Full Text :
- https://doi.org/10.1080/10428194.2019.1633635